The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
NF-κ B Promotes Breast Cancer Cell Migration and Metastasis by Inducing the Expression of the Chemokine Receptor CXCR4
Open accessAbstract
Metastasis of cancer cells is a complex process involving multiple steps including invasion, angiogenesis, and trafficking of cancer cells through blood vessels, extravasations, organ-specific homing, and growth. While matrix metalloproteinases, urokinase-type plasminogen activator, and cytokines play a major role in invasion and angiogenesis, chemokines such as stromal derived factor-1alpha (SDF-1alpha) and their receptors such as CXCR4 are thought to play a critical role in motility, homing, and proliferation of cancer cells at specific metastatic sites. We and others have previously reported that the extracellular signal-activated transcription factor NF-kappaB up-regulates the expression of matrix metalloproteinases, urokinase-type plasminogen activator, and cytokines in highly metastatic breast cancer cell lines. In this report, we demonstrate that NF-kappaB regulates the motility of breast cancer cells by directly up-regulating the expression of CXCR4. Overexpression of the inhibitor of kappaB (IkappaB) in breast cancer cells with constitutive NF-kappaB activity resulted in reduced expression of CXCR4 and a corresponding loss of SDF-1alpha-mediated migration in vitro. Introduction of CXCR4 cDNA into IkappaB-expressing cells restored SDF-1alpha-mediated migration. Electrophoretic mobility shift assays and transient transfection assays revealed that the NF-kappaB subunits p65 and p50 bind directly to sequences within the -66 to +7 region of the CXCR4 promoter and activate transcription. We also show that the cell surface expression of CXCR4 and the SDF-1alpha-mediated migration are enhanced in breast cancer cells isolated from mammary fat pad xenografts compared with parental cells grown in culture. A further increase in CXCR4 cell surface expression and SDF-1alpha-mediated migration was observed with cancer cells that metastasized to the lungs. Taken together, these results implicate NF-kappaB in the migration and the organ-specific homing of metastatic breast cancer cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“TMD231 cells were obtained from Dr. Harikrishna Nakshatri in 2009 and are a derivative of the MDA-MB-231 cell line (19).”
From Potentiation of carboplatin-mediated DNA damage by the Mdm2 modulator Nutlin-3a in a humanized orthotopic breast-to-lung metastatic model (2015) · cites this paper as [19]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Involvement of chemokine receptors in breast cancer metastasis
Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., et al. (2001) · Nature · doi:10.1038/35065016 · Cited by 5,340
Function and Activation of NF-kappaB in the Immune System
Baeuerle, P. A., & Henkel, T. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.001041 · Cited by 4,745
Cellular survival: a play in three Akts
Datta, S. R., Brunet, A., & Greenberg, M. E. (1999) · Genes & Development · doi:10.1101/gad.13.22.2905 · Cited by 4,216
NF-κB in cancer: from innocent bystander to major culprit
Karin, M., Cao, Y., Greten, F. R., & Li, Z. (2002) · Nature reviews. Cancer · doi:10.1038/nrc780 · Cited by 2,476
Changing views of the role of matrix metalloproteinases in metastasis
Chambers, A. F., & Matrisian, L. M. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.17.1260 · Cited by 1,582
Constitutive Activation of NF-κB during Progression of Breast Cancer to Hormone-Independent Growth
Nakshatri, H., Bhat‐Nakshatri, P., Martin, D. A., Goulet, R. J., & Sledge, G. W. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.7.3629 · Cited by 818
Self-citationBargou, R. C., Emmerich, F., Krappmann, D., Bommert, K., Mapara, M. Y., Arnold, W., Royer, H., Grinstein, E., Greiner, A., Scheidereit, C., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119849 · Cited by 757
Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer.
Sovak, M. A., Bellas, R. E., Kim, D. W., Zanieski, G., Rogers, A. E., Traish, A. M., & Sonenshein, G. E. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119848 · Cited by 720
Sato, H., & Seiki, M. (1993) · PubMed · Cited by 695
Ganju, R. K., Brubaker, S. A., Meyer, J., Dutt, P., Yang, Y., Qin, S., Newman, W., & Groopman, J. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.36.23169 · Cited by 614
Research works printed but not linked: 8
- Sato, 1993, Oncogene, 8, 395
- Andela, 2000, Cancer Res., 60, 6557
- Dong, 1999, Cancer Res., 59, 3495
- Shattuck-Brandt, 1997, Cancer Res., 57, 3032
- Bachelder, 2002, Cancer Res., 62, 7203
- Koshiba, 2000, Clin. Cancer Res., 6, 3530
- Murakami, 2002, Cancer Res., 62, 7328
- Scotton, 2002, Cancer Res., 62, 5930
Cited by
Sorted by citations
Items 401–500 of 640
Mazur, G. J., Butrym, A. K., Kryczek, I., Dłubek, D., Jaskuła, E., Lange, A., Kuliczkowski, K., & Jeleń, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098194 · Cited by 22
Kim, B., Kim, J., & Park, B. (2015) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25417 · Cited by 22
Xing, X., Ma, J.-H., Fu, Y., Zhao, H., Ye, X.-K., Han, Z., Jia, F.-J., & Li, X. (2019) · Medicine · doi:10.1097/md.0000000000017009 · Cited by 20
Activation of Nuclear Factor κB in Cerebral Arteriovenous Malformations
Aziz, M. M., Takagi, Y., Hashimoto, N., & Miyamoto, S. (2010) · Neurosurgery · doi:10.1227/neu.0b013e3181fa00f1 · Cited by 22
Tang, M., Yang, Y., Yu, J., Qiu, J., Chen, P., Wu, Y., Wang, Q., Xu, Z., Ge, J., Yu, K., et al. (2018) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.17-23712 · Cited by 22
Porecha, N. K., English, K., Hangoc, G., Broxmeyer, H. E., & Christopherson, K. W. (2006) · Stem Cells and Development · doi:10.1089/scd.2006.15.325 · Cited by 22
Self-citationAn Overall Picture of Chemokine Receptors: Basic Research and Drug Development
Chen, L., Pei, G., & Zhang, W. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043452749 · Cited by 22
Terceiro, L. E. L., Ikeogu, N. M., de Lima, M. F., Edechi, C. A., Nickel, B. E., Fischer, G., Leygue, E., McManus, K. J., & Myal, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512034 · Cited by 23
Pasquier, J., Abu-Kaoud, N., Abdesselem, H., Madani, A. Y., Hoarau-Véchot, J., Al-Thawadi, H., Vidal, F., Couderc, B. C., Favre, G., & Rafii, A. (2015) · BMC Cancer · doi:10.1186/s12885-015-1556-7 · Cited by 21
Jin, J., Zhang, Z., Wang, H., Zhan, Y., Li, G., Yang, H., Fei, Z., Xu, Y., & Li, W. (2018) · Experimental Cell Research · doi:10.1016/j.yexcr.2018.08.006 · Cited by 20
Manjeshwar, S., Lerner, M. R., Zang, X., Branam, D. E., Pento, J. T., Lane, M. M., Lightfoot, S. A., Brackett, D. J., & Jupe, E. R. (2004) · The Histochemical Journal · doi:10.1007/s10735-004-2185-7 · Cited by 21
Su, C., Chen, Z., Luo, H., Su, Y., Liu, W., Cai, L., Wang, T., Lei, Y., & Zhong, B. (2011) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-30-85 · Cited by 21
Murooka, T. T., Ward, S. E., & Fish, E. N. (2005) · Springer eBooks · doi:10.1007/0-387-24361-5_2 · Cited by 21
Ding, Y., Li, M., Zhang, J., Li, N., Xia, Z., Hu, Y., Wang, S., & Fan, G.-H. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.020271 · Cited by 21
Zhan, Y., Zhang, H., Li, J., Zhang, Y., Zhang, J., & He, L. (2015) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12536 · Cited by 20
Liu, Y., Su, C.-F., Shan, Y., Yang, S., & Ma, G. (2016) · Europe PMC (PubMed Central) · Cited by 20
Tari, H., Kessler, K., Trahearn, N., Werner, B., Vinci, M., Jones, C., & Sottoriva, A. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111283 · Cited by 19
DeCastro, A., Cherukuri, P., Balboni, A., & DiRenzo, J. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0194 · Cited by 20
Ethiraj, P., Veerappan, K., Samuel, S., & Sundaresan, S. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.04.058 · Cited by 20
Xue, M.-Q., Li, J., Sang, J., Su, L., & Yao, Y. (2017) · Oncotarget · doi:10.18632/oncotarget.16893 · Cited by 20
Martino, E. A., Bruzzese, A., Labanca, C., Mendicino, F., Lucia, E., Olivito, V., Stanzione, G., Zimbo, A. M., Pozzi, S., Neri, A., et al. (2024) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2024.2388567 · Cited by 19
Zhang, J., Lin, H. L., Wang, X., Zhang, D.-Q., Chen, J., Zhuang, Y., & Zheng, X.-L. (2017) · Cancer Biomarkers · doi:10.3233/cbm-160357 · Cited by 19
Jin, W., Gu, C., Zhou, L., Yang, X., Gui, M., Zhang, J., Chen, J., Dong, X., Yuan, Q., & Shan, L. (2020) · Oncology Reports · doi:10.3892/or.2020.7801 · Cited by 19
Shin, H. C., Seo, J., Kang, B. W., Moon, J. H., Chae, Y. S., Lee, S. J., Lee, Y. J., Han, S., Seo, S. K., Kim, J. G., et al. (2014) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2014.29.6.785 · Cited by 19
Zhan, Y., Zhang, H., Liu, R., Wang, W., Qi, J., & Zhang, Y. (2015) · Integrative Cancer Therapies · doi:10.1177/1534735415598224 · Cited by 19
New trends in the treatment of bone metastasis
Keller, E. T., Dai, J., Escara-Wilke, J. F., Hall, C. L., Ignatoski, K. M. W., Taichman, R. S., & Keller, J. M. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21540 · Cited by 20
Prajoko, Y. W., & Aryandono, T. (2019) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2019.20.5.1511 · Cited by 18
Xu, F., Wang, F., Di, M., Huang, Q., Min, W. Z., Hu, H., Jin, Y., Jian-kang, D., & Lai, M. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0597 · Cited by 18
Elghonaimy, E. A., El‐Shinawi, M., Ibrahim, S., Elghazaly, H. A., Abdeltawab, R. E., Nouh, M. A., El‐Mamlouk, T., & Mohamed, M. M. (2014) · FEBS Journal · doi:10.1111/febs.13124 · Cited by 18
The P-Rex1/Rac signaling pathway as a point of convergence for HER/ErbB receptor and GPCR responses
Kazanietz, M. G., Barrio‐Real, L., Casado‐Medrano, V., Baker, M. J., & López‐Haber, C. (2016) · Small GTPases · doi:10.1080/21541248.2016.1221273 · Cited by 18
Cai, C., Wang, L. ‐., Dong, Q., Wu, Z., Li, M. ‐., & Sun, Y. ‐. (2013) · Tissue Antigens · doi:10.1111/tan.12170 · Cited by 17
The CXCR4/SDF-1 Axis in the Development of Facial Expression and Non-somitic Neck Muscles
Yahya, I., Moroşan‐Puopolo, G., & Brand‐Saberi, B. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.615264 · Cited by 17
Ping, F., Liu, G.-J., Liu, Z., Li, H., Zhai, J., Li, S., Liu, Y., Li, B., & Wei, H. (2015) · PubMed Central · Cited by 17
Batool, R., Aziz, E., Tan, B. K. H., & Mahmood, T. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00731 · Cited by 17
To NFκB or not to NFκB: The Dilemma on How to Inhibit a Cancer Cell Fate Regulator.
Sorriento, D., Illario, M., Finelli, R., & Iaccarino, G. (2012) · Europe PMC (PubMed Central) · Cited by 17
Semaan, S. M., Wang, X., Stewart, P. A., Marshall, A. G., & Sang, Q. A. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.07.057 · Cited by 17
Konoplev, S. N., Lin, P., Yin, C. C., Lin, E., Nogueras‐González, G. M., Kantarjian, H. M., Andreeff, M., Medeiros, L. J., & Konopleva, M. Y. (2013) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2013.05.013 · Cited by 17
Therapeutic Implications of Targeting Energy Metabolism in Breast Cancer
Sakharkar, M. K., Shashni, B., Sharma, K., Dhillon, S. K., Ranjekar, P. R., & Sakharkar, K. R. (2013) · PPAR Research · doi:10.1155/2013/109285 · Cited by 17
Li, Q., O’Malley, M. E., Bartlett, D. L., & Guo, S. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-63 · Cited by 18
Wang, Y., Wang, Y., Liu, Z., Dong, W., Yang, B. V., Xia, X., Song, E., & Song, Y. (2018) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.8b00148 · Cited by 17
Lee, M. M. K., & Wong, Y. H. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0209052 · Cited by 17
Negative regulation of MHC class II gene expression by CXCR4
Sheridan, C. A., Sadaria, M. R., Bhat‐Nakshatri, P., Goulet, R. J., Edenberg, H. J., McCarthy, B. P., Chang, C., Srour, E. F., & Nakshatri, H. (2006) · Experimental Hematology · doi:10.1016/j.exphem.2006.03.013 · Cited by 17
Self-citationCXCR4/SDF-1α-mediated chemotaxis in an in vivo model of metastatic esophageal carcinoma.
Gros, S. J., Graeff, H., Drenckhan, A., Kurschat, N., Blessmann, M., Rawnaq, T., & Izbicki, J. R. (2012) · PubMed · Cited by 16
He, X., Fang, L., Wang, J., Yi, Y., Zhang, S., & Xie, X. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0294 · Cited by 16
Prognostic and therapeutic role of nuclear factor-kappa B (NF-kappaB) in breast cancer.
Ahmed, A. M. (2010) · PubMed · Cited by 15
CXCR4 is highly expressed at the tumor front but not in the center of prostate cancers
Delongchamps, N. B., Beuvon, F., Mathieu, J. R. R., Delmas, S., Metzger, I., Prats, H., & Cabon, F. (2014) · World Journal of Urology · doi:10.1007/s00345-014-1299-0 · Cited by 16
Identification of Matrine as a Novel Regulator of the CXCR4 Signaling Axis in Tumor Cells
Jung, Y. Y., Um, J., Narula, A. S., Namjoshi, O. A., Blough, B. E., Kumar, A. P., & Ahn, K. S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134731 · Cited by 15
Takabayashi, T., Takahashi, N., Okamoto, M., Yagi, H., Sato, M., & Fujieda, S. (2009) · Oral Oncology · doi:10.1016/j.oraloncology.2009.06.006 · Cited by 15
Migracins A and B, new inhibitors of cancer cell migration, produced by Streptomyces sp.
Arai, Y., IINUMA, H., Ikeda, Y., Igarashi, M., Hatano, M., Kinoshita, N., Ukaji, T., Simizu, S., & Umezawa, K. (2012) · The Journal of Antibiotics · doi:10.1038/ja.2012.112 · Cited by 15
Thulasitha, W. S., Umasuthan, N., Revathy, K. S., Whang, I., & Lee, J. (2015) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2015.03.012 · Cited by 15
Toor, J. S., Singh, S., Sharma, A., & Arora, S. K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106815 · Cited by 15
Manni, S., Toscani, D., Mandato, E., Brancalion, A., Tubi, L. Q., Macaccaro, P., Cabrelle, A., Adami, F., Zambello, R., Gurrieri, C., et al. (2014) · Leukemia · doi:10.1038/leu.2014.178 · Cited by 15
Clinical validation of nuclear factor kappa B expression in invasive breast cancer
Agrawal, A. K., Pielka, E., Lipiński, A., Jeleń, M., Kielan, W., & Agrawal, S. (2018) · Tumor Biology · doi:10.1177/1010428317750929 · Cited by 15
Aravindan, S., Natarajan, M., Herman, T. S., & Aravindan, N. (2013) · Clinical & Experimental Metastasis · doi:10.1007/s10585-013-9580-y · Cited by 14
Anaya‐Eugenio, G. D., Carcache, P. J. B., Ninh, T. N., Ren, Y., Soejarto, D. D., & Kinghorn, A. D. (2020) · Phytotherapy Research · doi:10.1002/ptr.6930 · Cited by 14
Pradubyat, N., Giannoudis, A., Elmetwali, T., Mahalapbutr, P., Palmieri, C., Mitrpant, C., & Ketchart, W. (2021) · Planta Medica · doi:10.1055/a-1307-3997 · Cited by 14
Subramaniam, B., Arshad, N. M., Malagobadan, S., Misran, M., Nyamathulla, S., Mun, K. S., & Nagoor, N. H. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13040439 · Cited by 15
Role of Nuclear Factor-kappa B Signaling in Anticancer Properties of Indole Compounds
Ahmad, A., Sakr, W., & Rahman, K. (2011) · Journal of Experimental & Clinical Medicine · doi:10.1016/j.jecm.2011.01.001 · Cited by 14
Lei, J.-Q., Wu, C., Wang, X., & Wang, H. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.02.022 · Cited by 14
Coordinated Upregulation of COX-2 and NF-κB Is a Steady Feature of Laryngeal Carcinogenesis
Kourelis, K. G., Sotiropoulou‐Bonikou, G., Vandoros, G. P., Repanti, M., Varakis, I., & Goumas, P. (2007) · ORL · doi:10.1159/000099229 · Cited by 14
Qiao, E., Chen, D., Li, Q., Feng, W., Yu, X., Zhang, X., Xia, L., Jin, J. Y., & Yang, H. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27680 · Cited by 13
RetractedStress Exposure in Significant Relationships Is Associated with Lymph Node Status in Breast Cancer
Renzi, C., Vadilonga, V., Gandini, S., Perinel, G., Rotmensz, N., Didier, F., Rescigno, M., & Pravettoni, G. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149443 · Cited by 13
Furusato, B., & Rhim, J. S. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-267-4_2 · Cited by 13
Zhang, B., Guan, C.-C., Wan-tao, C. H. E. N., Zhang, P., Yan, M., Jiu-hui, S. H. I., Qin, C., & Yang, Q. (2007) · Chinese Medical Journal · doi:10.1097/00029330-200710020-00020 · Cited by 13
Wang, L. P., Jin, J., Lv, F., Cao, J., Zhang, J., Wang, B.-Y., Shao, Z.-M., Hu, X., & Wang, Z. (2015) · PubMed · Cited by 13
Sheng, X., Zhou, Y., Song, Q., Zhou, D., & Liu, Q. (2011) · Oncology Reports · doi:10.3892/or.2011.1596 · Cited by 12
Anticancer potential of metformin: focusing on gastrointestinal cancers
Khezri, M. R., Malekinejad, H., Zolbanin, N. M., & Ghasemnejad‐Berenji, M. (2021) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-021-04256-8 · Cited by 12
Labrecque, M. P., Takhar, M., Jagdeo, J. M., Tam, K. J., Chiu, C., Wang, T.-Y., Préfontaine, G. G., Cox, M., & Beischlag, T. V. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099214 · Cited by 12
Ju, A., Cho, Y.-C., Kim, B. R., Lee, S., Le, H. T. T., Vuong, H. L., & Cho, S. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.4178 · Cited by 13
Wang, H., Dong, Z., Yan, L., Yang, S., Xu, H., Chen, S., Wang, W., Yang, Q., & Chen, C. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29755 · Cited by 12
Corcoran, K. E., & Rameshwar, P. (2007) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0396 · Cited by 12
In vivo modeling of the EGFR family in breast cancer progression and therapeutic approaches
Simond, A. M., & Muller, W. J. (2020) · Advances in cancer research · doi:10.1016/bs.acr.2020.04.004 · Cited by 12
Zhang, B., Guan, C.-C., Chen, W., Zhang, P., Yan, M., Jiu-hui, S. H. I., Qin, C., & Yang, Q. (2007) · PubMed · Cited by 12
Stromal cell derived factor-1, CXCR4 and CXCR7 gene transcripts in pterygia
Bamdad, S., Khademi, B., Chenari, N., Taseh, A., & Razmkhah, M. (2016) · Journal of Current Ophthalmology · doi:10.1016/j.joco.2016.10.006 · Cited by 11
Rosenbaum, S. R., Hughes, C. J., Fields, K. M., Purdy, S. C., Gustafson, A. L., Wolin, A. R., Hampton, D., Shrivastava, N., Turner, N., Danis, E. P., et al. (2025) · Science Advances · doi:10.1126/sciadv.adt0504 · Cited by 11
Identifying the optimal dose of ritonavir in the treatment of malignancies
Moawad, E. Y. (2013) · Metabolic Brain Disease · doi:10.1007/s11011-013-9448-5 · Cited by 11
Kim, B., Min, Y.-H., & Park, B. (2020) · Planta Medica · doi:10.1055/a-1107-3272 · Cited by 11
Sekuła, M., Miękus, K., & Majka, M. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2383 · Cited by 11
Innate immunity: Bacterial cell‐wall muramyl peptide targets the conserved transcription factor YB‐1
Ламан, А. Г., Lathe, R., Savinov, G. V., Shepelyakovskaya, A. O., Boziev, K. M., Baidakova, L. K., Chulin, A. N., Brovko, F. A., Svirshchevskaya, E. V., Kotelevtsev, Y. V., et al. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.05.028 · Cited by 11
Stem Cell Biology in Health and Disease
Dittmar, T., & Zänker, K. S. (2009) · Springer eBooks · doi:10.1007/978-90-481-3040-5 · Cited by 11
NF-κB and Hsp70 are involved in the phospholipase Cγ1 signaling pathway in colorectal cancer cells
Li, X., Hua, L., Deng, F., Bai, X., Zeng, W., Lu, D., Su, Y., & Luo, S.-Q. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.05.025 · Cited by 11
Inhibitors for Metastasis Development
Lang, K., Drell, T. L., Zaenker, K. S., & Entschladen, F. (2006) · Recent Patents on Anti-Cancer Drug Discovery · doi:10.2174/157489206775246511 · Cited by 11
Inhibition of active HIV-1 replication by NF-κB inhibitor DHMEQ
Miyake, A., Ishida, T., Yamagishi, M., Hara, T., Umezawa, K., Watanabe, T., & Horie, R. (2010) · Microbes and Infection · doi:10.1016/j.micinf.2010.02.004 · Cited by 10
Chu, C., Sheen, Y., Cha, S.-T., Hu, Y., Tan, C., Chiu, H., Chang, C.-C., Chen, M., Kuo, M., & Jee, S. (2013) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2013.06.011 · Cited by 10
The pro-tumorigenic responses in metastatic niches: an immunological perspective
Mirzapour, M. H., Heidari‐Foroozan, M., Razi, S., & Rezaei, N. (2022) · Clinical & Translational Oncology · doi:10.1007/s12094-022-02950-4 · Cited by 11
Kim, C., Kim, D., Nam, D., Chung, W., Ahn, K. S., KIM, S., Choi, S., Shim, B. S., Cho, S. K., & Ahn, K. S. (2014) · Phytotherapy Research · doi:10.1002/ptr.5140 · Cited by 10
Gibberellin JRA-003: A Selective Inhibitor of Nuclear Translocation of IKKα
Annand, J. R., Henderson, A. R., Cole, K. S., Maurais, A. J., Becerra, J., Liu, Y., Weerapana, E., Koehler, A. N., Mapp, A. K., & Schindler, C. S. (2020) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.9b00613 · Cited by 10
Kim, B., Kim, Y. C., & Park, B. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3568 · Cited by 10
Chia, D. J., Singh, A., Lin, Y., Popko, N., Mastro, D., Liu, Y., Tran, T. M., King, J. K., Rao, D. S., & Hoffmann, A. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116193 · Cited by 9
Ke, C., Tomiyasu, H., Lin, Y., Huang, W., Huang, H.-H., Chiang, H.-C., & Lin, C. (2022) · BMC Veterinary Research · doi:10.1186/s12917-021-03093-4 · Cited by 9
Liu, Z., Meng, D., Wang, J., Cao, H., Feng, P., Wu, S., Wang, N., Dang, C., Hou, P., & Xia, P. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05198-6 · Cited by 9
Kim, Y., Kim, I., & Nam, T. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.2055 · Cited by 9
Mkaouar, L., Endo, Y., Mochizuki, M., Nishimura, R., Sasaki, N., & Nakagawa, T. (2011) · Journal of Veterinary Medical Science · doi:10.1292/jvms.10-0580 · Cited by 9
Molecular Pathology of Cancer Metastasis: Suggestions for Future Therapy
Angelucci, A., & Alesse, E. (2012) · Humana Press eBooks · doi:10.1007/978-1-61779-615-9_18 · Cited by 9
Tazaki, T., Miyazaki, K., Hiyama, E., Nakamoto, T., Sakai, R., Yamasaki, N., Honda, Z., Noda, M., Miyasaka, N., Sueda, T., et al. (2008) · Genes to Cells · doi:10.1111/j.1365-2443.2007.01156.x · Cited by 9
Expression of NFkB1, GADD45A and JNK1 in salivary gland carcinomas of different histotypes.
Göbel, G., Szanyi, I., Revesz, P. Z., Bauer, M., Gerlinger, I., Németh, Á., Ember, I., Gőcze, K., & Gombos, K. (2013) · PubMed · Cited by 9
Yu, F., Lin, M., Hsu, S., Yu, C.-C., Huang, Y., Kuo, Y., & Chung, J. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3537 · Cited by 9
Eskandari, E., & Motalebzadeh, J. (2019) · Cancer Genetics · doi:10.1016/j.cancergen.2019.09.004 · Cited by 9
Ben‐Baruch, A. (2005) · Springer eBooks · doi:10.1007/1-4020-3414-8_11 · Cited by 9
Chung, Y.-H., Jhun, B. H., Ryu, S., Kim, H., Kim, C.-M., Kim, B., Kim, Y., & Lee, S.-J. (2007) · BMB Reports · doi:10.5483/bmbrep.2007.40.3.341 · Cited by 9
Metadata
- Authors
- Helbig, G., Christopherson, K. W., Bhat-Nakshatri, P., Kumar, S., Kishimoto, H., Miller, K. D., Broxmeyer, H. E., & Nakshatri, H.
- Affiliations
- Indiana University Indianapolis (US)
- Walther Cancer Foundation (US)
- Corresponding author
- Nakshatri, Harikrishna
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-06
- Volume
- 278
- Issue
- 24
- Pages
- 21631-21638
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1980790180
- Cited by
- 639
- References
- 42
- Citations by year
- 2026: 6 · 2025: 12 · 2024: 15 · 2023: 12 · 2022: 19 · 2021: 14 · 2020: 23 · 2019: 18 · 2018: 33 · 2017: 28 · 2016: 34 · 2015: 30 · 2014: 35 · 2013: 42 · 2012: 18
- FWCI
- 16.82
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- IUScholarWorks (Indiana University) (submittedVersion)
- Funders
- National Institutes of Health (5r21ca082208-02)
- National Heart, Lung, and Blood Institute (HL67384, R01HL067384)
- National Cancer Institute (CA82208)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK053674, DK53674, T32DK007519)
- Topics
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Keywords
- NF-κB, breast cancer, metastasis, cell migration, CXCR4, chemokine receptors, SDF-1α, chemokine signaling, IκB, transcriptional regulation, lung metastasis
- MeSH terms
- Animals, Breast Neoplasms, Cell Movement, Chemotaxis, Flow Cytometry, Genetic Vectors, Humans, Neoplasm Metastasis, Neoplasm Transplantation, Plasmids, Promoter Regions, Genetic, Ribonucleases, RNA, Messenger, Transcription, Genetic, Transfection, Tumor Cells, Cultured, Up-Regulation, Gene Expression Regulation, Neoplastic, NF-kappa B, DNA, Complementary, COS Cells, Receptors, CXCR4, Matrix Metalloproteinases, Mitogen-Activated Protein Kinases, Transcription Factor RelA, NF-kappa B p50 Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review